Precision Medicine in Oncology

Automated Clinical Trial Matching Based on NGS Yields High Rates of False Positives

March 6th 2021, 6:15pm

Article

According to new research, 88% of trials initially matched to patients were eventually classified as false positives when manually screened by a provider.

FDA Grants Full, Expanded Approval to Lorlatinib in ALK-Positive NSCLC

March 5th 2021, 3:30pm

Article

The FDA has granted full approval to lorlatinib, expanding its indication to include frontline treatment for patients with anaplastic lymphoma kinase (ALK)-positive metastatic NSCLC.

ACCC and ASCO Collaborative Targets Disparities in Cancer Clinical Trials

February 17th 2021, 7:00pm

Article

ACCC president Randall Oyer, MD, gives insight into the ongoing collaboration between the ACCC and ASCO to foster minority participation in cancer clinical trials.

The Untapped Potential of Cell and Gene Therapy

February 16th 2021, 9:00pm

Article

Excitement around gene therapy is back and greater than before. Although safety remains a concern, investigators are breaking ground in cell and gene therapy, and many believe that ultimately, a string of cancer cures will follow.

FDA Approves First Once-daily Oral MET Inhibitor for Metastatic NSCLC

February 3rd 2021, 11:00pm

Article

Tepmetko (tepotinib) was FDA approved for the treatment of adult patients with metastatic non-small cell lung cancer with mesenchymal-epithelial transition (MET) exon 14 skipping alterations.

Number of Personalized Medicines Doubled in 4 Years, New Report Says

December 28th 2020, 2:00pm

Article

A report published by the Personalized Medicine Coalition shows that the number of personalized medicines on the market grew at the highest rate ever recorded by the organization from 2016-2020.

Dr Michael Korn Highlights a Key Takeaway From the Precision Medicine Session at QCCA’s Fall Meeting

December 27th 2020, 3:00pm

Video

During the panel on precision medicine at the Quality Cancer Care Alliance (QCCA) Fall Leadership Summit, the speakers discussed testing every patient upfront with a broad molecular assessment and bringing clinical research to the patient.

The Top 5 Most-Read Precision Oncology Articles of 2020

December 27th 2020, 11:30am

Article

A top-5 roundup of some of 2020's advancements in the precision oncology space.

PMC Report Shows Number of Personalized Medicines Doubled in 4 Years

December 22nd 2020, 7:40pm

Article

A report published by the Personalized Medicine Coalition (PMC) shows that the number of personalized medicines on the market is growing at the highest rate ever recorded by the organization.

Managing the “Knowledge Explosion” a Key Challenge of Precision Oncology

December 20th 2020, 11:00am

Article

Managing the constantly evolving selection of therapies in oncology can be difficult, but is of the utmost importance to get the right treatment to the right patient, agreed a panel at Patient-Centered Oncology Care® 2020.